The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

Abbott (ABT): An 'income machine'

 Apr 14, 2009 03:30 PM UTC
Return Risk
+4.82% MID
Tracked Blogger
Symbol Sentiment Start Return Closed
ABT Positive 04/14/09 +5.76% 09/17/09

Graphic_arrow1 Via BloggingStocks:  

Filed under: Newsletters, Abbott Laboratories (ABT), Stocks to Buy

"Abbott Laboratories (NYSE: ABT) is continuing its long record of rewarding shareholders," notes Alex Kolb In Zacks Elite, pointing to its 341st consecutive quarter of dividends since 1924.


"Abbott is a global, broad-based health care company that develops, manufactures and markets pharmaceuticals and medical products, including nutritionals, devices and diagnostics.


"The company employs more than 68,000 people and markets its products in more than 130 countries.


"The company recently released new data, showing that a combination of its new TriLipix triglycerides medicine and a low dose of AstraZeneca's Crestor cholesterol drug are better than the individual pills for treating heart problems.

Continue reading Abbott (ABT): An 'income machine'

Abbott (ABT): An 'income machine' originally appeared on BloggingStocks on Tue, 14 Apr 2009 10:30:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments



Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati



 Graphic_website1 Read the rest of original post »



Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch